A Combined-Formulation Tablet of Lamivudine/Nevirapine/Stavudine: Bioequivalence Compared With Concurrent Administration of Lamivudine, Nevirapine, and Stavudine in Healthy Indian Subjects
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. UNAIDS The Joint United Nations Programme on HIV/AIDS Web site http://www.unaids.org/Unaids/EN/Resources/Epidemiology/epidemicupdateslides.asp
2. U.S. Department of Health and Human Services (DHHS) HIV/AIDS medical practice guidelines http://www.aidsinfo.nih.gov/guidelines/
3. Metabolic complications associated with HIV protease inhibitor therapy;Nolan;Drugs,2003
4. A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients;Leeuwen;AIDS,2003
5. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team;Staszewski;N Engl J Med.,1999
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?;Int. Journal of Clinical Pharmacology and Therapeutics;2017-05-01
2. The role of formulation on the pharmacokinetics of antiretroviral drugs;Expert Opinion on Drug Metabolism & Toxicology;2014-05-30
3. Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations;Indian Pediatrics;2014-03
4. Selective Determination of Antiretroviral Agents Tenofovir, Emtricitabine, and Lamivudine in Human Plasma by a LC-MS-MS Method for a Bioequivalence Study in Healthy Indian Subjects;Journal of Chromatographic Science;2010-10-01
5. Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings;AIDS Research and Therapy;2010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3